SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Orchid Pharma - Quaterly Results

10 May 2023 Evaluate
The Revenue for the quarter ended  March 2023 of Rs. 2099.01 millions grew by 16.46 % from Rs. 1802.34 millions.Net Profit witnessed a 47332.37% growth almost the double from Rs. 1.39 millions to Rs. 659.31  millions  of same quarter last year.The company reported a good operating profit of 414.17 millions compared to 312.25 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 2099.01 1802.34 16.46 6658.98 5569.74 19.56 6658.98 5569.74 19.56
Other Income 17.29 17.47 -1.03 194.31 90.03 115.83 194.31 90.03 115.83
PBIDT 414.17 312.25 32.64 1030.49 662.62 55.52 1030.49 662.62 55.52
Interest 74.84 44.59 67.84 322.26 320.12 0.67 322.26 320.12 0.67
PBDT 731.43 267.66 173.27 1100.33 342.50 221.26 1100.33 342.50 221.26
Depreciation 72.12 266.27 -72.91 547.86 870.21 -37.04 547.86 870.21 -37.04
PBT 659.31 1.39 47332.37 552.47 -527.71 -204.69 552.47 -527.71 -204.69
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 659.31 1.39 47332.37 552.47 -527.71 -204.69 552.47 -527.71 -204.69
Equity 408.16 408.16 0.00 408.16 408.16 0.00 408.16 408.16 0.00
PBIDTM(%) 19.73 17.32 13.89 15.48 11.90 30.08 15.48 11.90 30.08

Orchid Pharma Share Price

564.10 -3.40 (-0.60%)
16-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1693.15
Dr. Reddys Lab 1221.25
Cipla 1230.75
Zydus Lifesciences 939.20
Lupin 2326.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×